Extended-spectrum β-lactamase TEM-4 in Pseudomonas aeruginosa  by Poirel, Laurent et al.
CORRESPONDENCE 
Extended-spectrum p-lactamase TEM-4 in 
Pseudomonas aeruginosa 
Clirt Microbiol Infect 1999; 5: 651-652 
Extended-spectrum j)-lactamases (ESBLs) constitute a 
growing class of p-lactamases which are often plasmid- 
mediated and are most commonly expressed in 
enterobacterial species [1,2]. The majority of ESBLs are 
point mutant derivatives of the narrow-spectrum p- 
lactamases TEM-1, TEM-2 or SHV-1. They are 
Ambler class A p-lactamases, hydrolyzing to different 
extents oxyiminocephalosporins, such as cefiriaxone, 
cefotaxime and ceftazidime, and monobactams such as 
aztreonam. The activity of these penicillinases remains 
inhibited by clavulanic acid [l]. Such enzymes have 
rarely been reported in Pseudornonas aeruginosa, only 
TEM-43 and SHV2a being known in rare isolates in 
France [3,4], and SHV-5 in an isolate from Thailand 
[5]. PER-1, a class A ESBL not related to TEM or SHV 
derivatives, however, is widespread in l? aeruginosa 
isolates from Turkey [6,7], while OXA-18, the only 
class D enzyme conferring an ESBL phenotype, was 
recently identified in a I? aeruginosa strain from an 
Italian patient in Paris [8]. Other class D ESBLs whose 
activity is not clavulanic acid-inhibited, such as the 
OXA-10 derivatives, OXA-11, OXA-14, OXA-16, 
and OXA-19, and the Om-3 derivative, OXA-15, 
have been reported mostly as plasmid-mediated in l? 
aeruginosa [9-131. 
In order to detect ESBL-producing l? aeruginosa 
strains, we have systematically screened all l? aeruginosa 
strains isolated in our hospitals for ESBL by placing a 
clavulanic acid-containing disk next to a cefiazidime 
disk in a double-disk synergy test as suggested for 
Enterobacteriaceae [14]. In December 1996, an image 
of synergy was detected for l? aeruginosa STEL. This 
strain was isolated from a urinary tract infection of a 
man who was transferred to our institution (Raymond 
PoincarC Hospital) from another suburban hospital of 
Paris. A strain with a similar resistance phenotype was 
isolated from a rectal swab of this patient but no other 
carriers were identified in the same hospital unit in 
December 1996. J? aeruginosa STEL was identified 
using the API 33 G N  system (bioMtrieux, Marcy- 
l’Etoile, France). 
Minimum inhibitory concentrations were deter- 
mined by an agar dilution method as previously 
described [8] in the presence or absence of a p-lactam 
inhibitor (clavulanic acid, tazobactam). I? aeruginosa 
strain STEL was resistant to ticarcillin and piperacillin, 
but susceptible to ticarcillin/clavulanic acid or piper- 
acillin/tazobactam (Table 1). Resistance towards oxy- 
iminocephalosporins was of low level, especially to 
cefiazidime. The ceftazidime activity was antagonized 
by clavulanic acid or tazobactam addition, suggesting 
the presence of an ESBL. 
In order to identify this ESBL, dot-blot hybridiza- 
tions were performed using internal probes for blapER-1, 
blasav-3, blaTEM and b l a o x p - l s  [8]. Only the blUTEM 
probe gave a positive hybridization signal with extract- 
ed l? aeruginosa STEL genomic DNA. Using blaTEM- 
specific primers (TEM-lA, 5’-ATGAGTATTCAA 
GCTTAATC AGTGAGGCA-3’), an 861-bp P C R  
product was amplified and sequenced with an Applied 
Biosystem sequencer (model ABI 377). DNA sequence 
analysis and deduction of the protein sequence revealed 
TEM-4. This enzyme, first identified in Esckevichia coli 
[15,16], differs from the narrow-spectrum (j-lactamase 
TEM-1 by four amino acid substitutions, L21F, 
E104K. G238S, and T265M. The E104K and G238S 
changes were shown to be responsible for the extended 
hydrolysis spectrum of TEM-4 that was initially con- 
sidered to indicate a cefotaximase rather than a 
ceftazidimase [15,16]. Since b l a ~ ~ ~ . 4  was found to be 
plasmid-located in E. coli, four different plasmid DNA 
extraction methods were used for l? aeruginosa STEL 
[8]. None of these methods yielded plasmid DNA from 
this l? aeruginosa strain. Mating-out experiments using 
either l? aeruginosa PU21 or an in vitro obtained 
ciprofloxacin-resistant E. coli JM 109 mutant as recipient 
strains also failed [8]. The blaTEM-4 gene is therefore 
likely to be chromosome-borne in l? aeruginosa STEL, 
CATTTTCGTGTCG-3’, TEM-lB, 5’-ACCAAT- 
Table 1 MICs of P-lactams for P aeruginosa isolate STEL 
MICs (mg/L) 
Antibiotic+ Antibiotic+ 
Antibiotic Clavulanic acid Tazobactam 
(I-Lactam alone (2 mR/L) (4 m d L )  
~ 
Amoxycillin 
Ticarcillin 
Piperacillin 
Cephalothin 
Cefoxitin 
Cefiazidime 
Cefotaxime 
Cefepime 
Imipenem 
Meropeneni 
Moxalactam 
Aztreonam 
>512 
>512 
32 
>512 
2512 
8 
128 
8 
4 
1 
16 
16 
>512 
32 
4 
ND 
ND 
4 
32 
ND 
ND 
ND 
4 
3 ‘. 
>512 
32 
8 
ND 
ND 
1 
16 
ND 
ND 
ND 
4 
7 
1 
~~ 
ND, not determined. 
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just as it is the case of other clavulanic acid-inhibited 
ESBLs in I? aeruginosa such as blasm-a,, blasHv-5,blmm-ls, 
and b h p ~ ~ - ~  (in the initial strain PERO) [4-6,8]. A 
lower level of resistance to oxyiminocephalosporins was 
found in I? aeruginosa STEL as compared to that 
observed in E. coli [16]. This may result from either the 
absence of plasmid location of ~ ~ U T E M - ~  in I? aenrginosa 
STEL, or a weaker expression of this gene in I! aeru- 
ginosa, or both. With the use of 5’CS (5’-GGCATC- 
CAAGCAGCAAG-3’) and 3’CS (5’-AAGCAGACT- 
TGACC TGA-3’) specific primers for class 1 integrons 
[17], a 1400-bp PCR-amplified fiagment was obtained 
from E aeruginosa STEL genomic DNA which did not 
hybridize with the internal probe for bhTEM. Thus, the 
location of b l a ~ ~ ~ - 4  in a typical class 1 integron was 
rejected as the result of ~ ~ U T E M - ~  acquisition in 
aeruginosa STEL. 
This study constitutes the second report of a TEM- 
derivative ESBL in E aeruginosa. Together with previous 
reports, it indicates that I? aeruginosa strains may become 
a hidden reservoir for ESBL genes, as is already known 
to be the case for oxacillinase extended-spectrum 
derivatives [18]. In the case of ~ ~ u T E M - ~ ,  its presence in 
E aenrginosa may result either from point mutations 
of a pre-existing blaTEM-1 gene or from transfer of 
b l a ~ ~ ~ - 4 ,  perhaps from an enterobacterial species. From 
a clinical point of view, it is worthwhile mentioning 
that ESBLs are difficult to detect in E aenrginosa. Their 
detection by the double-disk synergy test may be 
rendered more efficient by placing cefiazidime and 
clavulanic acid disks closer to each other. ‘Candidate 
strains’ for clavulanic acid-inhibited ESBL-producing 
I? aeruginosa are ticarcdin and cefiazidime resistant, but 
susceptible to ticarcillin-clavulanate. 
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